BIOACTIVX

Live / Allowed — Publication / registration review complete (as of 02 Apr 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Sept 2025 filing date already counts against anyone who files later.

Record

Serial number
99415403
Mark type
Design + words
Filed
26 Sept 2025
Published for opposition
21 Apr 2026
Attorney of record
Alan Taboada

Goods and services

  • Class 005 — Pharmaceuticals: Transdermal patches for use in scar prevention in incisional wounds; Skin patches for the transdermal delivery of pharmaceuticals featuring bioactive polymer nanoparticles for use in scar prevention in incisional wounds by inducing skin repair and inflammation control; Impregnated pads in the nature of wound dressings containing medicated preparations, namely, bioactive polymers; Tissues impregnated with pharmaceutical lotions featuring bioactive polymer nanoparticles for use in controlling skin inflammation and for superficial burn treatment; Adhesive skin bandage patches for medical use in treating skin wounds; Dressings for wounds, namely, cellulose wound dressings, foam wound dressings, and polymer based wound dressings; Materials for dressing wounds, namely, cellulose ribbons, foam pads, dermal substitutes, and topical creams; Adhesive compositions for medical use, namely, medical adhesives for binding wounds; Pharmaceutical preparations for treating atopic dermatitis, contact dermatitis, and superficial burns; Dressing retention materials, namely, elastic bandages; self-adhesive dressings; Sticking plasters for medical use; wound dressings in the nature of pressure bandages; Pads impregnated with medicated preparations, namely, cellulose pads and foam pads, for the treatment of partial and full thickness wounds; Tissues impregnated with pharmaceutical lotions for treating eczema; Sponge material impregnated with antiseptics for healing wounds; Medicated creams for use in treating atopic dermatitis and contact dermatitis; Medicated skin care preparations; biological tissue-based skin substitutes for the medical purposes of regenerating tissue; anti-inflammatory pharmaceutical preparations and substances

Owner

Prosecution history

  • 27 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 26 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 26 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 26 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 23 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 23 Feb 2026 — NON-FINAL ACTION E-MAILED
  • 23 Feb 2026 — NON-FINAL ACTION WRITTEN
  • 18 Feb 2026 — ASSIGNED TO EXAMINER
  • 17 Feb 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
  • 17 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 26 Sept 2025 — APPLICATION FILING RECEIPT MAILED
  • 26 Sept 2025 — NEW APPLICATION ENTERED

View this trademark record on Marksy